Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide offerings.

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Key Takeaways A pill to treat obesity caused liver injury in a clinical trialPfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity ...

Medications like Ozempic, Wegovy, and Zepbound have helped many Americans lose weight, but there are still some ...

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

The drugmaker said it would stop studying danuglipron after a participant had a possible drug-induced liver injury.